Cancer in one person can behave very differently than it might in another person. That’s because each person’s genes are unique. So some new cancer treatments can target the individual’s unique genetic fingerprint. Scientists are exploring possible new targets in lymphoma.

The common skin condition where splotches of lighter skin spread unpredictably over the body may be frustrating. But on the bright side, it lowers the risk of skin cancer threefold.

Women with higher risk for ovarian cancer are encouraged to go through a rather intense screening process. Fortunately, the screening process isn’t too stressful to bear.

High levels of certain proteins appear to stimulate tumor growth. Newly discovered proteins can help doctors identify patients who are at increased risk for aggressive prostate cancer.

Dietary supplements can be tricky business. When the FDA cracks down on dangerous supplements, sometimes they pop up again elsewhere. WOW is a new supplement on the market that could cause serious problems.

Not all women respond to a common breast cancer drug called tamoxifen . Not to worry–these women can now be identified and switched to another medication before the disease turns deadly.

Many Americans may enjoy drinking on New Year's Eve, but they don't top the charts. In fact, the US is not even among the 25 "drunkest" countries in world alcohol consumption rates.

Fatigue can be part of the new normal for breast cancer survivors. An ancient practice may help to bring these ladies new energy.

Genes are at the heart of a number of cancers. When cancer-promoting genes are identified, they can sometimes become targets for new drugs.

Adriamycin ( doxorubicin ) can be a good chemotherapy treatment for breast cancer. But, for some women, it can lead to heart damage. A recent study found a way to predict who is at risk.